Dosage form: oral tablets, orally disintegrating tablets (Zyprexa Zydis), intramuscular injection (Zyprexa IM), long-acting intramuscular injection (Zyprexa Relprevv)Drug class: Atypical antipsychotics Medically reviewed by Carmen Pope, BPharm. Last updated on Apr 23, 2024....
10 mg (32 μmol), 15 mg (48 μmol) or 20 mg (64 μmol). It begins disintegrating in the mouth within seconds, allowing its contents to be subsequently swallowed with or without liquid. ZYPREXA ZYDIS (olanzapine orally disintegrating tablets) also contains the following inactive ingredients: ...
Administration Of ZYPREXA ZYDIS (Olanzapine Orally Disintegrating Tablets) After opening sachet, peel back foil on blister. Do not push tablet through foil. Immediately upon opening the blister, using dry hands, remove tablet andplace entire ZYPREXA ZYDIS in the mouth. Tablet disintegration occurs rap...
Immediately upon opening the blister, using dry hands, remove tablet and place entire ZYPREXA ZYDIS in the mouth. Tablet disintegration occurs rapidly in saliva so it can be easily swallowed with or without liquid. 2.4 ZYPREXA IntraMuscular: Agitation Associated with Schizophrenia and Bipolar I ...
ZYPREXA IntraMuscular is indicated for the treatment of acute agitation associated with schizophrenia and bipolar I mania. Efficacy was demonstrated in 3 short-term (24 hours of IM treatment) placebo-controlled trials in agitated adult inpatients with: schizophrenia or bipolar Idisorder (manic or mixed...
ZYPREXA IntraMuscular is indicated for the treatment of acute agitation associated with schizophrenia and bipolar I mania. Efficacy was demonstrated in 3 short-term (24 hours of IM treatment) placebo-controlled trials in agitated adult inpatients with: schizophrenia or bipolar Idisorder (manic or mixed...
ZYPREXA IntraMuscular is indicated for the treatment of acute agitation associated with schizophrenia and bipolar I mania. Efficacy was demonstrated in 3 short-term (24 hours of IM treatment) placebo-controlled trials in agitated adult inpatients with: schizophrenia or bipolar Idisorder (manic or mixed...
ZYPREXA IntraMuscular is indicated for the treatment of acute agitation associated with schizophrenia and bipolar I mania. Efficacy was demonstrated in 3 short-term (24 hours of IM treatment) placebo-controlled trials in agitated adult inpatients with: schizophrenia or bipolar Idisorder (manic or mixed...